Clinical Evaluation of Panchatikta Ghrita and Nalpamaradi Taila in the Management of Vicharchika(Eczema)

Central Council for Research in Ayurvedic Sciences0 个研究点目标入组 120 人开始时间: 待定最近更新: 2024年7月22日

试验速览

暂无简介。

•1.Patient with Status Eczematous condition.
•2.Patient with poorly controlled Hypertension ( >160/100 mmHg)
•3.Patient with uncontrolled Diabetes Mellitus having HbA1C > 8%
•4.Patient on medication with corticosteroids, phototherapy,
•biologics, antidepressants and any other drugs that may
•have an influence on the outcome of the study.
•5.Alcoholic and/or drug abuser
•6.Symptomatic patients with clinical evidence of heart failure.
•7.Known case of HIV and AIDS.
•8.Known case of Malignacy.
•9.Patienttaking participation in any other clinical trial.
•10.Woman who are planning for conception/pregnant or lactating.
•11.Patientwith concurrent serious hepatic disorders (defined as aspartate amino (AST) and/ or Alanine AminoTransferase(ALT) >2times upper normal limit or Renal Disorders (defined as S. Creatinine >1.2mg/dl), Severe pulmonary Dysfunction (uncontrolled Bronchial Asthma and /or Chronic obstructive Pulmonary Disease (COPD).
•12.H/o hypersensitivity to any of the trial drugs or their ingredients.
•13.Patient who have completed participation in any other
•clinical trial during the past three months.
•14.Any other condition which the Investigator thinks may
•jeopardize the study.

发起方